Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Testicular Cancer Clinical Trials
Testicular Cancer clinical trials are recruiting across 27 cities. Here are the cities with the most active studies:
Testicular Cancer Trial Phases
9 research organizations are sponsoring testicular cancer trials.
About Testicular Cancer
Testicular cancer develops in the testicles and is the most common cancer in young men ages 15-35. It has a very high cure rate, even when diagnosed at advanced stages. Treatment includes surgery, chemotherapy, and radiation therapy.
Clinical trials are advancing new treatments for testicular cancer. Currently, 11 studies are recruiting a combined 5,458 participants across the United States. Research is being conducted by 9 organizations including Children's Oncology Group, Memorial Sloan Kettering Cancer Center, University of Sydney and 6 others.
2026 Testicular Cancer Research Landscape
As of July 2026, the testicular cancer clinical trial landscape includes 11 actively recruiting studies across 27 cities in the United States. These studies are collectively seeking 5,458 participants, with an average enrollment target of 496 per study.
The research spans multiple phases of development: 3 studies are in PHASE3, 3 studies are in PHASE2, 2 studies are in NA, 1 study is in PHASE1. The presence of Phase 3 trials indicates that some testicular cancer treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 9 different organizations, including Children's Oncology Group, Memorial Sloan Kettering Cancer Center, University of Sydney, University of Southern California, University of California, Irvine, and 4 others.
Geographically, testicular cancer trials are most concentrated in Indianapolis, Indiana (3 trials); Birmingham, Alabama (2 trials); New York, New York (2 trials); Loma Linda, California (2 trials); Mobile, Alabama (1 trial) and 7 other cities.
Featured Testicular Cancer Studies
Highlighted recruiting studies for testicular cancer, selected by enrollment size and research scope.
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of t...
Molecular Epidemiology of Pediatric Germ Cell Tumors
A Non-Therapeutic Study that aims to establish a cohort of GCT survivors to understand short term and long-term adverse effects of treatment and to conduct molecular analyses to improve risk stratification.
Germ Cell Tumor and Testicular Tumor DNA Registry
This study is being done to create a registry to help us learn more about germ cell tumors (GCT) and other testicular tumors. The registry will include people with these tumors and also relatives and unrelated people without these tumors. This study will help us learn more about the prevention, diagnosis, treatment and outcome of these tumors. Studying relatives of patients and people unrelated to...
Frequently Asked Questions About Testicular Cancer Clinical Trials
Are there testicular cancer clinical trials near me?
Yes, there are 11 testicular cancer clinical trials currently recruiting across 27+ cities in the United States, including Indianapolis, Indiana; Birmingham, Alabama; New York, New York. Browse the studies above to find one at a location convenient for you.
How do I join a testicular cancer clinical trial?
To join a testicular cancer clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are testicular cancer clinical trials free?
Yes, participation in testicular cancer clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of testicular cancer treatments are being studied?
Current testicular cancer clinical trials are testing a range of approaches across PHASE3 (3 studies), PHASE2 (3 studies), NA (2 studies), PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 9 research organizations.
Is it safe to participate in testicular cancer clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 14, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 14, 2026 · Data from ClinicalTrials.gov